Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-...
Leadership
Matthew Angel Ph.D.
President, CEO & Director
Justin Trojanowski CPA
VP of Finance, Corp. Controller, Treasurer, Secretary and Principal Financial & Accounting Officer
